EXOSENS SAS (EXENS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EXENS - FR001400Q9V2 - Common Stock
53.8 EUR
+0.4 (+0.75%)
Overall EXENS gets a fundamental rating of 5 out of 10. We evaluated EXENS against 53 industry peers in the Aerospace & Defense industry. EXENS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EXENS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
- In the past year EXENS was profitable.
- In the past year EXENS had a positive cash flow from operations.
1.2 Ratios
- EXENS has a Return On Assets (3.54%) which is in line with its industry peers.
- Looking at the Return On Equity, with a value of 7.14%, EXENS is doing worse than 62.26% of the companies in the same industry.
- With a Return On Invested Capital value of 7.97%, EXENS perfoms like the industry average, outperforming 58.49% of the companies in the same industry.
- EXENS had an Average Return On Invested Capital over the past 3 years of 7.01%. This is below the industry average of 9.24%.
- The 3 year average ROIC (7.01%) for EXENS is below the current ROIC(7.97%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 7.14% | ||
| ROIC | 7.97% |
ROA(3y)2.89%
ROA(5y)N/A
ROE(3y)7.53%
ROE(5y)N/A
ROIC(3y)7.01%
ROIC(5y)N/A
1.3 Margins
- EXENS has a better Profit Margin (7.79%) than 69.81% of its industry peers.
- Looking at the Operating Margin, with a value of 18.28%, EXENS belongs to the top of the industry, outperforming 94.34% of the companies in the same industry.
- With an excellent Gross Margin value of 73.86%, EXENS belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
- EXENS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.28% | ||
| PM (TTM) | 7.79% | ||
| GM | 73.86% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.14%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXENS is destroying value.
- EXENS has less shares outstanding than it did 1 year ago.
- EXENS has a better debt/assets ratio than last year.
2.2 Solvency
- EXENS has an Altman-Z score of 4.82. This indicates that EXENS is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.82, EXENS belongs to the best of the industry, outperforming 81.13% of the companies in the same industry.
- The Debt to FCF ratio of EXENS is 4.73, which is a neutral value as it means it would take EXENS, 4.73 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of EXENS (4.73) is better than 67.92% of its industry peers.
- A Debt/Equity ratio of 0.61 indicates that EXENS is somewhat dependend on debt financing.
- The Debt to Equity ratio of EXENS (0.61) is worse than 60.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 4.73 | ||
| Altman-Z | 4.82 |
ROIC/WACC0.86
WACC9.25%
2.3 Liquidity
- EXENS has a Current Ratio of 2.51. This indicates that EXENS is financially healthy and has no problem in meeting its short term obligations.
- EXENS has a better Current ratio (2.51) than 88.68% of its industry peers.
- A Quick Ratio of 1.67 indicates that EXENS should not have too much problems paying its short term obligations.
- EXENS's Quick ratio of 1.67 is amongst the best of the industry. EXENS outperforms 86.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
- EXENS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.95%, which is quite impressive.
- EXENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.04%.
- EXENS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.36% yearly.
EPS 1Y (TTM)102.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%875.18%
Revenue 1Y (TTM)35.04%
Revenue growth 3Y33.36%
Revenue growth 5YN/A
Sales Q2Q%20.13%
3.2 Future
- The Earnings Per Share is expected to grow by 23.94% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 12.79% on average over the next years. This is quite good.
EPS Next Y52.91%
EPS Next 2Y37.16%
EPS Next 3Y30.01%
EPS Next 5Y23.94%
Revenue Next Year17.96%
Revenue Next 2Y16.32%
Revenue Next 3Y14.79%
Revenue Next 5Y12.79%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- EXENS is valuated quite expensively with a Price/Earnings ratio of 72.70.
- Based on the Price/Earnings ratio, EXENS is valued a bit more expensive than 60.38% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.87. EXENS is valued rather expensively when compared to this.
- With a Price/Forward Earnings ratio of 28.87, EXENS can be considered very expensive at the moment.
- EXENS's Price/Forward Earnings ratio is in line with the industry average.
- EXENS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 72.7 | ||
| Fwd PE | 28.87 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXENS.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXENS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.42 | ||
| EV/EBITDA | 25.34 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as EXENS's earnings are expected to grow with 30.01% in the coming years.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y37.16%
EPS Next 3Y30.01%
5. Dividend
5.1 Amount
- EXENS has a yearly dividend return of 0.18%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.74, EXENS is paying slightly less dividend.
- Compared to an average S&P500 Dividend Yield of 1.82, EXENS's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.16%
EPS Next 3Y30.01%
EXOSENS SAS / EXENS.PA FAQ
What is the fundamental rating for EXENS stock?
ChartMill assigns a fundamental rating of 5 / 10 to EXENS.PA.
What is the valuation status for EXENS stock?
ChartMill assigns a valuation rating of 3 / 10 to EXOSENS SAS (EXENS.PA). This can be considered as Overvalued.
Can you provide the profitability details for EXOSENS SAS?
EXOSENS SAS (EXENS.PA) has a profitability rating of 4 / 10.
How financially healthy is EXOSENS SAS?
The financial health rating of EXOSENS SAS (EXENS.PA) is 7 / 10.
What is the expected EPS growth for EXOSENS SAS (EXENS.PA) stock?
The Earnings per Share (EPS) of EXOSENS SAS (EXENS.PA) is expected to grow by 52.91% in the next year.